POZN

Pozen, Inc. News Headlines

$7.38
*  
0.05
0.68%
Get POZN Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading POZN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    POZN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
BIOD To Report Data Next Month, HALO Shines On Deal News, TTPH Gets Ignited
12/17/2014 11:26:00 PM - RTT News


Pozen: YOSPRALA Gets Second Complete Response Letter From FDA - Quick Facts
12/17/2014 6:48:00 AM - RTT News


Pozen Inc. Is A Great Opportunity For Investors
12/13/2014 2:36:00 PM - Seeking Alpha


InsiderInsights.com Daily Round Up 12/3/14: VRX, PSEC, MATR, OCIP
12/4/2014 12:28:00 AM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts: Part 5
12/1/2014 9:59:00 AM - Seeking Alpha


Sanofi backs out of commercialization deal with Pozen
12/1/2014 7:41:00 AM - Seeking Alpha


Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick
9/16/2014 8:38:00 AM - Seeking Alpha


A Tale Of 2 Portfolios
9/13/2014 6:16:00 AM - Seeking Alpha


Great Buying Opportunity In Pozen Shares
7/30/2014 10:11:00 AM - Seeking Alpha


Pozen Resubmits PA NDA, PDUFA In Two Months?
7/3/2014 9:47:00 AM - Seeking Alpha


Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha


Pozen, Inc.: Buy This Biotech For Growth And Income
5/10/2014 9:13:00 AM - Seeking Alpha


Pozen Is Overvalued, More So Now After Recent FDA Rejection - Here Is Why
4/28/2014 11:57:00 AM - Seeking Alpha


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Notes From One-On-One Meetings During San Fran Biotech Week - Day 2
1/23/2014 9:05:00 AM - Seeking Alpha


Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha


POZEN Inc. And Chelsea Therapeutics Primed For Big Gains On The Road To PDUFA
10/23/2013 2:51:00 PM - Seeking Alpha


Pozen Seeks Partner For Safer Aspirin By Year-End
8/7/2013 12:02:00 PM - Seeking Alpha


FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha


A Deal For Pozen's PA Could Send Shares Soaring
3/6/2013 1:48:00 PM - Seeking Alpha


The Dendreon Bear Raid Of 2009: Chasing The Perpetrators
3/4/2013 5:00:00 AM - Seeking Alpha


3 Attractively Valued Biotechs From BIO CEO 2013
2/14/2013 9:56:00 AM - Seeking Alpha


4 Small Cap Biopharmas With Near-Term Catalysts
2/11/2013 8:34:00 AM - Seeking Alpha


Understanding The Market Opportunity For Pozen's Safer Aspirin
1/16/2013 9:34:00 AM - Seeking Alpha


8 High Growth Stocks At A Big Discount And With Low PEG, Low Debt
12/26/2012 10:25:00 AM - Seeking Alpha